HLB bioStep Co.,Ltd. (KOSDAQ:278650)

HLB bioStep Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	100,604	122,820	176,390	242,875	327,966	219,226
Market Cap Growth	-48.50%	-30.37%	-27.37%	-25.95%	49.60%	14.63%
Enterprise Value	92,691	134,125	168,104	226,210	341,037	227,757
Last Close Price	1191.00	1454.00	2095.00	3090.00	4650.00	3169.24
PE Ratio	-	-	-	-	-	19.87
PS Ratio	1.36	1.66	3.03	4.60	3.80	3.40
PB Ratio	1.00	1.22	1.51	2.35	4.54	3.30
P/TBV Ratio	1.10	1.34	1.73	2.43	4.79	3.50
P/FCF Ratio	90.38	110.34	-	204.19	206.70	-
P/OCF Ratio	32.60	39.80	-	46.78	50.61	25.90
EV/Sales Ratio	1.25	1.81	2.89	4.28	3.95	3.54
EV/EBITDA Ratio	-	-	-	98.80	36.23	18.93
EV/EBIT Ratio	-	-	-	-	64.24	25.29
EV/FCF Ratio	83.27	120.50	-	190.18	214.94	-
Debt / Equity Ratio	0.31	0.31	0.30	0.59	1.27	0.25
Debt / EBITDA Ratio	-	-	-	26.48	9.74	1.35
Debt / FCF Ratio	27.64	27.64	-	50.98	57.76	-
Net Debt / Equity Ratio	-0.12	-0.12	-0.10	-0.09	-0.07	0.09
Net Debt / EBITDA Ratio	3.22	3.22	1.46	-4.25	-0.58	0.49
Net Debt / FCF Ratio	-11.30	-11.30	0.59	-8.19	-3.42	-0.53
Asset Turnover	0.46	0.46	0.34	0.31	0.65	0.76
Inventory Turnover	12.09	12.09	11.33	10.96	14.15	8.80
Quick Ratio	1.07	1.07	1.20	1.15	8.36	1.14
Current Ratio	1.26	1.26	1.35	1.23	8.57	1.75
Return on Equity (ROE)	-18.60%	-18.60%	-8.80%	-0.06%	-1.27%	19.00%
Return on Assets (ROA)	-3.33%	-3.33%	-4.80%	-0.43%	2.49%	6.67%
Return on Invested Capital (ROIC)	-8.32%	-8.95%	-13.15%	0.25%	7.64%	13.51%
Return on Capital Employed (ROCE)	-8.00%	-8.00%	-10.70%	-1.10%	3.30%	11.50%
Earnings Yield	-18.85%	-15.44%	-4.86%	-0.07%	-0.31%	5.03%
FCF Yield	1.11%	0.91%	-11.68%	0.49%	0.48%	-5.08%
Payout Ratio	-	-	-	-	-	10.26%
Buyback Yield / Dilution	-0.82%	-0.82%	-9.45%	-9.59%	-0.02%	-1.35%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.